OBJECTIVE: To examine the relationship between plasma gelsolin levels and mortality following surgery or trauma. BACKGROUND: Few simple predictive diagnostic tests are available to predict mortality following surgery or trauma. We hypothesize that plasma concentrations of gelsolin, a protein that responds to injured tissue, might be a predictor of patient outcomes. METHODS: We conducted a prospective, observational study in the surgical intensive units (ICU) at a tertiary care teaching hospital. A total of 31 patients were enrolled in the study. Chart abstraction was used to gather data about patient demographics, clinical characteristics, and clinical outcomes. Plasma gelsolin concentrations were assessed serially on day 0 through day 5. RESULTS: Low plasma gelsolin levels were associated with increased risk of death occurring in the ICU. Plasma gelsolin levels lower than 61 mg/L predicted longer ICU stay, prolonged ventilator dependence, and increased overall in-hospital mortality. CONCLUSION: Plasma gelsolin is a potential prognostic biomarker for critically ill surgical patients. Plasma gelsolin replacement may have therapeutic application.
OBJECTIVE: To examine the relationship between plasma gelsolin levels and mortality following surgery or trauma. BACKGROUND: Few simple predictive diagnostic tests are available to predict mortality following surgery or trauma. We hypothesize that plasma concentrations of gelsolin, a protein that responds to injured tissue, might be a predictor of patient outcomes. METHODS: We conducted a prospective, observational study in the surgical intensive units (ICU) at a tertiary care teaching hospital. A total of 31 patients were enrolled in the study. Chart abstraction was used to gather data about patient demographics, clinical characteristics, and clinical outcomes. Plasma gelsolin concentrations were assessed serially on day 0 through day 5. RESULTS: Low plasma gelsolin levels were associated with increased risk of death occurring in the ICU. Plasma gelsolin levels lower than 61 mg/L predicted longer ICU stay, prolonged ventilator dependence, and increased overall in-hospital mortality. CONCLUSION: Plasma gelsolin is a potential prognostic biomarker for critically ill surgical patients. Plasma gelsolin replacement may have therapeutic application.
Authors: H Ito; H Kambe; Y Kimura; H Nakamura; E Hayashi; T Kishimoto; S Kishimoto; H Yamamoto Journal: Gastroenterology Date: 1992-05 Impact factor: 22.682
Authors: Hasan Kara; Selim Degirmenci; Ahmet Ak; Aysegul Bayir; Seyit Ali Kayis; Mehmet Uyar; Murat Akinci; Demet Acar; Metin Kocacan; Fikret Akyurek Journal: Bosn J Basic Med Sci Date: 2015-01-08 Impact factor: 3.363
Authors: Sherry H-Y Chou; Po-Shun Lee; Rachael G Konigsberg; Dana Gallacci; Terry Chiou; Ken Arai; Suzanne Simmons; David Bauer; Steven K Feske; Eng H Lo; MingMing Ning Journal: Stroke Date: 2011-09-22 Impact factor: 7.914
Authors: John Audley; Emily F Gliniewicz; Kol A Zarember; Hanna S Hong; Gal Wald; Douglas B Kuhns; Elizabeth Kang; Harry L Malech; Anthony F Suffredini; Robert J Noveck; Mark J Dinubile; Susan L Levinson; Thomas P Stossel; John I Gallin Journal: Inflammation Date: 2020-09-04 Impact factor: 4.092
Authors: Robert Bucki; Alina Kulakowska; Fitzroy J Byfield; Malgorzata Zendzian-Piotrowska; Marcin Baranowski; Michal Marzec; Jessamine P Winer; Nicholas J Ciccarelli; Jan Górski; Wieslaw Drozdowski; Robert Bittman; Paul A Janmey Journal: Am J Physiol Cell Physiol Date: 2010-09-01 Impact factor: 4.249
Authors: Janeen R Jordan; Ernest E Moore; Sagar S Damle; Phillip Eckels; Jeffrey L Johnson; Jonathan P Roach; Jasmina S Redzic; Kirk C Hansen; Anirban Banerjee Journal: J Surg Res Date: 2007-11 Impact factor: 2.192
Authors: Alina Kułakowska; Nicholas J Ciccarelli; Qi Wen; Barbara Mroczko; Wiesław Drozdowski; Maciej Szmitkowski; Paul A Janmey; Robert Bucki Journal: BMC Neurol Date: 2010-11-01 Impact factor: 2.474